Literature DB >> 6226308

Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.

O Rollman, A Vahlquist.   

Abstract

Synthetic and natural retinoids were analysed in epidermis, dermis, subcutis and serum of twenty-seven patients treated with etretinate (0.6-1.0 mg/kg/day) for 1-36 months. The concentrations of etretinate (including its major metabolite) in serum and normal-appearing epidermis were 150-600 ng/ml and 50-350 ng/g, respectively. The serum and epidermal values were significantly correlated (P less than 0.05). The drug progressively accumulated in the subcutis attaining a maximum value of 15,500 ng/g. After the treatment, etretinate disappeared from the epidermis within 1 week. By contrast, the drug remained in the subcutis for several months after cessation of treatment. The epidermal composition of endogenous retinoids changed during etretinate therapy as reflected in an increased ratio of 3-dehydroretinol to all-trans retinol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6226308     DOI: 10.1111/j.1365-2133.1983.tb04618.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  17 in total

1.  Visual toxicity of synthetic retinoids.

Authors:  R D Brown; C E Grattan
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

Review 2.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

3.  Vitamin A supplementation redirects the flow of retinyl esters from peripheral to central organs of neonatal rats raised under vitamin A-marginal conditions.

Authors:  Joanna K Hodges; Libo Tan; Michael H Green; A Catharine Ross
Journal:  Am J Clin Nutr       Date:  2017-03-15       Impact factor: 7.045

Review 4.  Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.

Authors:  F G Larsen; F Nielsen-Kudsk; P Jakobsen; K Weismann; K Kragballe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

5.  A phase 1 and pharmacokinetic study using the aromatic retinoic acid analogue dichloroetretinate (Ro 12-7554).

Authors:  B A Zonnenberg; A von Dijk; C P Vendrik; J H Schornagel; A Struyvenberg
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 6.  Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.

Authors:  M L Bouvy; M C Sturkenboom; M C Cornel; L T De Jong-Van den Berg; B H Stricker; H Wesseling
Journal:  Pharm Weekbl Sci       Date:  1992-04-24

7.  In vivo skin penetration of acitretin in volunteers using three sampling techniques.

Authors:  C Surber; K P Wilhelm; D Bermann; H I Maibach
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

8.  Biosynthesis of 3,4-didehydroretinol from retinol by human skin keratinocytes in culture.

Authors:  O Rollman; E J Wood; M J Olsson; W J Cunliffe
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

Review 9.  Synthetic retinoids in dermatology.

Authors:  E H Heller; N J Shiffman
Journal:  Can Med Assoc J       Date:  1985-05-15       Impact factor: 8.262

10.  Psoriasis and vitamin A. Plasma transport and skin content of retinol, dehydroretinol and carotenoids in adult patients versus healthy controls.

Authors:  O Rollman; A Vahlquist
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.